Research · Sep 3, 2026
Boeing FY2025 revenue ~$80-83B (+14-17% YoY recovery from FY2024 trough $66.5B post-Alaska Airlines incident impact) but adj. EPS still negative ~-$1 to -$2.50 reflecting cumulative operating losses on 737 MAX production constraint + 777-9 delays + selected defense program issues. 737 MAX production at ~25-30/month FY2025 (target 38/month FY2026 + 50+/month FY2027 historical baseline). Spirit AeroSystems acquisition closed Oct 2025 for ~$4.7B Boeing stock + assumed debt — vertical integration of largest fuselage supplier addresses supply chain quality issues. CEO Kelly Ortberg since Aug 2024 (succeeded Dave Calhoun). FY2026 thesis: 737 MAX production rate progressively recovers toward FAA target 38/month; 777-9 first delivery occurs in 2026 (multi-year delays from original 2020); Spirit integration delivers operational quality improvements; BCA achieves operating profitability by FY2027; key risks: sustained production constraints, 777-9 further delays, Defense cost overruns continuing.
Research · Jun 9, 2026
GE Aerospace CEO is optimistic about more aircraft engine orders from China after Trump-Xi talks. What it means for GE's commercial aerospace pipeline.
Research · Jun 8, 2026
Boeing's new 737 Max final assembly line in Everett, Washington starts production July 6. What the catalyst means for BA's recovery thesis.
Research · Apr 23, 2026
Boeing's Q1 2026 revenue beat of $22.2B vs $21.99B expected and improved EPS of -$0.20 vs -$0.66 expected signal operational recovery progress. The stock surged 4.71% pre-market. The thesis hinges on sustained delivery execution, with Q2 commercial jet delivery volumes being the critical test.
Research · Apr 13, 2026
Artemis II's safe return on April 11, 2026, de-risks NASA's lunar program, favoring contractors like LMT and NOC with direct hardware roles. We rank six stocks by exposure, ranking LMT highest for its Orion primacy and steady growth. Risks include delays and competition from private launchers.
Research · Apr 13, 2026
Trump's warning over China's alleged anti-air missiles to Iran heightens Middle East risks, positioning Lockheed Martin and Northrop Grumman for backlog growth amid record demand, while XLE grapples with oil volatility. LMT and NOC boast strong financials—$75B/$44B sales guidance, robust FCF—trading at reasonable multiples with 38-50% 1Y gains. Investors should favor defense over energy as U.S. aid ramps.
Research · Apr 13, 2026
Boeing's SLS faces Trump NASA scrutiny, per April 11 Bloomberg report, boosting Lockheed, Northrop, Rocket Lab, BWXT, and Intuitive Machines for lunar bases and nuclear propulsion. LMT and NOC top ranked for stability; BA lags. Article analyzes financials and exposure.
Research · Apr 10, 2026
Ex-RAF official's warning on UK's ballistic missile gaps signals procurement urgency, favoring RTX and LMT's Patriot/THAAD dominance amid $450B+ combined backlogs. Financial strength (double-digit margins, robust FCF) positions them for billions in contracts, while BA remains sidelined. Bullish: 15-20% upside on European ramp.
Research · Apr 10, 2026
As Australia prepares for a significant defense buildout in response to rising geopolitical tensions, US defense contractors are poised to benefit. Companies like Lockheed Martin and Raytheon Technologies are well-positioned to capture substantial contracts, while others like Northrop Grumman and General Dynamics also stand to gain from increased spending. This article explores the potential winners in this evolving landscape.
Research · Apr 10, 2026
European ministers' Ukraine visit highlights surging military aid and reconstruction, benefiting US defense leaders like RTX and LMT via munitions replenishment, and infrastructure firms CAT and PWR through rebuild contracts. With Europe committing billions, these six stocks offer tailwinds from 5-20% revenue growth and strong FCF. Ranked by conviction: RTX tops for balanced exposure.
Research · Apr 10, 2026
Trump's NATO withdrawal threat over Iran forces Europe's rearming, boosting US defense primes while commercial aerospace surges. RTX and LMT lead with massive backlogs and F-35/missile exposure; all six analyzed with FY2025 financials show tailwinds.
Research · Apr 10, 2026
Trump's NATO exit threats are forcing Europe to invest billions in defense manufacturing, creating export bonanzas for US primes like RTX and LMT. With backlogs surging and guidance upbeat, these firms offer compelling tailwinds—ranked by exposure and value.
Research · Apr 10, 2026
SpaceX's confidential IPO filing spotlights ARK ETFs with private stakes and suppliers like NOC, RTX, LHX, and BA. These positions offer leveraged upside from valuation unlock and ecosystem expansion, ranked by conviction from ARKK top.
Research · Apr 10, 2026
SpaceX's confidential IPO filing at ~$1.75T has buoyed aerospace stocks, validating the sector. Rocket Lab shines with growth and backlog, while LMT offers defense stability; BA and SPCE lag. Bullish on RKLB as prime beneficiary.
Research · Apr 9, 2026
Oil's record high on April 7 spotlights winners like COP, XOM, CVX with surging FCF, versus losers BA, AMZN, JPM facing cost/inflation pressures. Ranked picks favor lean producers.
Research · Apr 9, 2026
US regulators' plan to ease power limits on space-based broadband, per Reuters April 8, boosts satellite internet viability. AST SpaceMobile, Rocket Lab, Planet Labs, Boeing, Lockheed Martin, and Northrop Grumman emerge as top US-listed winners, ranked by growth and valuation in the SpaceX-fueled economy.
